Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.5K Buy
245
+24
+11% +$2.77K 0.01% 288
2025
Q4
$23.3K Buy
221
+111
+101% +$10.4K 0.01% 358
2025
Q3
$9.23K Buy
110
+14
+15% +$1.15K ﹤0.01% 538
2025
Q2
$7.6K Sell
96
-215
-69% -$17.1K ﹤0.01% 553
2025
Q1
$27.9K Buy
311
+99
+47% +$9.24K 0.02% 256
2024
Q4
$21.1K Sell
212
-87
-29% -$8.97K 0.01% 300
2024
Q3
$34K Sell
299
-157
-34% -$18.7K 0.02% 215
2024
Q2
$56.5K Hold
456
0.04% 142
2024
Q1
$60.2K Sell
456
-7
-2% -$863 0.04% 141
2023
Q4
$50.5K Buy
+463
New +$48.1K 0.04% 138

Other funds holding MRK

WealthCollab's MRK Position: Q1 2026 in Review

WealthCollab increased its Merck (MRK) stake by 11% in Q1 2026, buying an estimated $2.77K and bringing the position to 245 shares worth $29.5K. The position accounts for 0.01% of the portfolio, ranked #288.

WealthCollab first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $60.2K in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • WealthCollab held 245 shares of Merck worth $29.5K as of Q1 2026.
  • WealthCollab bought 24 Merck shares in Q1 2026, an estimated $2.77K.
  • Merck made up 0.01% of WealthCollab's portfolio in Q1 2026, its #288 holding.
  • WealthCollab first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Merck position peaked at $60.2K in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.